News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Bayer
NEWS
JOBS
IN THE PRESS
NEWS
Study: Bayer Drug Prevents Heart Attack, Stroke
October 19, 2005
·
1 min read
Swiss Army Medicine
October 19, 2005
·
1 min read
Drug Development
Bayer’s Levitra Impotence Drug Works For Up To 10 Hours
October 19, 2005
·
1 min read
Bayer: Aspirin Cuts Mortality Rate In Gut Cancer
October 19, 2005
·
1 min read
FDA Bans Bayer Antibiotic For Poultry Use; Citing Human Threat
October 19, 2005
·
1 min read
BioCapital
Biotech’s Full Monte
October 19, 2005
·
1 min read
Gurus Find Portfolio Cures In Biotech
October 19, 2005
·
1 min read
AWARDS
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Press Releases
Bayer Completes Acquisition of Perfuse Therapeutics
June 17, 2026
·
3 min read
Press Releases
Bayer’s AMBELVIST® (gadoquatrane) Receives FDA Approval for Contrast-Enhanced MRI to Detect and Visualize Lesions with Abnormal Vascularity in the Central Nervous System and Non-CNS Body Regions
June 15, 2026
·
10 min read
Press Releases
Dr. Jost Reinhard Appointed President of Bayer’s Radiology Business
June 9, 2026
·
3 min read
Press Releases
Bayer Announces Global Consumer Health Leadership Changes to Accelerate Growth
June 8, 2026
·
3 min read
Press Releases
Phase III FIND‑CKD Results Show Bayer’s KERENDIA® (finerenone) Improved eGFR Slope and Reduced Risk of a Composite Kidney-Cardiovascular Outcome in Adults with Non‑Diabetic Chronic Kidney Disease
June 5, 2026
·
16 min read
Press Releases
Bayer to Present First Full FIND-CKD Results Investigating KERENDIA® (finerenone) in Non-Diabetic Chronic Kidney Disease at ERA 2026
June 2, 2026
·
12 min read
Press Releases
ASCO 2026: Bayer Shares New Findings for NUBEQA® (darolutamide) Regarding Cognitive Decline in Men with Advanced Prostate Cancer Compared to Enzalutamide in Phase II ARACOG Head-to-Head Trial
June 1, 2026
·
14 min read
Press Releases
Olema Oncology Announces Clinical Trial Collaboration and Supply Agreement with Bayer to Evaluate OP-3136 in Combination with NUBEQA® (darolutamide) in Metastatic Castration-Resistant Prostate Cancer
May 26, 2026
·
5 min read
Press Releases
ASCO 2026: Bayer to Present New Data Across Oncology Portfolio
May 21, 2026
·
19 min read
Press Releases
Bayer’s KERENDIA® (finerenone) Granted Priority Review of Supplemental New Drug Application by U.S. FDA for Treatment of Adults with Type 1 Diabetes and Chronic Kidney Disease
May 21, 2026
·
13 min read
